Merus (MRUS) Ownership - Who owns Merus?

Industry: @Biotechnology
17 days until earnings call

Profile

Industry
Biotechnology
Address
Uppsalalaan 17
Phone
+31 302538800
Employees
229
Web
https://www.merus.nl

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
3.69B
P/E Ratio
N/A
Total Cash
337.5M
Projected Growth
N/A
Total Debt
11.53M
Revenue
38.34M
Risk (Beta)
1.31
Dividend Yield
N/A
Total Cash/Share
5.01
Total Debt/Equity
N/A
Revenue/Share
0.70 USD as % of share price

Fundamentals

MRUS
Capitalization
3.69B
P/E Ratio
N/A
Risk (Beta)
1.31
Dividend Yield
N/A
Total Cash
337M
Total Cash/Share
5.01
Total Debt
11.5M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.70%
Revenue
38.3M
ROE
N/A
Book Value
349M
P/B Ratio
10.57
Cash Flow
N/A
Earnings
-2.73
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
5.97M
Current Ratio
5.23
Current Revenue Per Employee
34449.78
Dividends Per Share - Security
N/A
EBITDA
-164.04M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-35.78
Shares Held By Institutions
3.68B
Shares Outstanding - Current
67.4M
Total Liabilities
149M
Total Volume MTD
N/A
Value
-1
Gain YTD
99.309
View a ticker or compare two or three
MRUS
Daily Signal changed days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of therapeutics for cancer treatment

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
Uppsalalaan 17
Phone
+31 302538800
Employees
229
Web
https://www.merus.nl